DUBLIN–(BUSINESS WIRE)–The “U.S. Copper Scrap Market Size, Share & Trends Analysis Report by Application (Wire…
Submission supported by comprehensive analytical and clinical data from new Phase I bridging pharmacokinetics study…
Basel/Allschwil, Switzerland, June 17, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced…
COVID-19 related challenges negatively impacted patient recruitment Ad Hoc Announcement Pursuant to Art. 53 LR…
–Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options…
SAN MATEO, Calif.–(BUSINESS WIRE)–NextPhase, an innovative data cloud management solutions provider, announced that it has…
NEW YORK–(BUSINESS WIRE)–Entegris, Inc. (Nasdaq: ENTG) (“Entegris”) today announced that its wholly-owned subsidiary, Entegris Escrow…
TOKYO, Jun 17, 2022 – (JCN Newswire) – NEC Australia, a wholly-owned subsidiary of NEC…
Acumen Research and Consulting recently published report titled “Edible Films and Coatings Market Size, Share,…
Helps establish a dedicated “terminal-use only” chassis program HOUSTON–(BUSINESS WIRE)–The U.S. Department of Agriculture (USDA)…
A market leader in providing cloud and software platforms for broadband service providers, Calix launches…
BASEL, Switzerland, June 16, 2022 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires…
NEW YORK, June 16, 2022 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences…
Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time LAVAL, Quebec,…
SAN CARLOS, Calif., June 16, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
Clinical update call featuring LAVA-051 investigator Dr. Arnon Kater and Company management summarized initial Phase…
BRIDGEWATER, N.J., June 16, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…
Management to discuss progress on its programs, annual stockholders’ meeting proposals Webcast to be held…
Extends Cash Runway into 2H 2024 BOSTON, June 16, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals,…
HAMPTON, N.J., June 16, 2022 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…